https://clarametyx.koii.dev/publication/the-natural-human-adaptive-igg-specific-immune-response-is-skewed-towards-non-protective-tail-domains-of-dnabii-proteins-frontiers-in-immunology-2026/2026-04-29T16:45:54-04:00https://clarametyx.koii.dev/publication/mycobacterium-abscessus-biofilm-cleared-from-murine-lung-by-monoclonal-antibody-against-bacterial-dnabii-proteins-journal-of-cystic-fibrosis-2025/2026-04-29T16:46:18-04:00https://clarametyx.koii.dev/publication/disruption-of-nontuberculous-mycobacteria-biofilms-induces-a-highly-vulnerable-to-antibiotic-killing-phenotype-biofilm-2023/2026-04-29T16:46:39-04:00https://clarametyx.koii.dev/publication/monoclonal-antibodies-that-target-extracellular-dnabii-proteins-or-the-type-iv-pilus-of-nontypeable-haemophilus-influenzae-nthi-worked-additively-to-disrupt-2-genera-biofilms-biofilm-2022/2026-04-29T16:46:58-04:00https://clarametyx.koii.dev/publication/z-form-extracellular-dna-is-a-structural-component-of-the-bacterial-biofilm-matrix-cell-2021/2026-04-29T16:47:15-04:00https://clarametyx.koii.dev/publication/a-humanized-monoclonal-antibody-potentiates-killing-by-antibiotics-of-diverse-biofilm-forming-respiratory-tract-pathogens-antimicrobial-agents-and-chemotherapy-asm-journals-2022/2026-04-29T16:47:38-04:00https://clarametyx.koii.dev/publication/crumbling-the-castle-targeting-dnabii-proteins-for-collapsing-bacterial-biofilms-as-a-therapeutic-approach-to-treat-disease-and-combat-antimicrobial-resistance-antibiotics-mdpi-journals-2022/2026-04-29T16:47:58-04:00https://clarametyx.koii.dev/publication/the-extracellular-innate-immune-effector-hmgb1-limits-pathogenic-bacterial-biofilm-proliferation-journal-of-clinical-investigation-2021/2026-04-29T16:48:15-04:00https://clarametyx.koii.dev/publication/nontypeable-haemophilus-influenzae-newly-released-nrel-from-biofilms-by-antibody-mediated-dispersal-versus-antibody-mediated-disruption-are-phenotypically-distinct-biofilm-2020/2026-04-29T16:48:36-04:00https://clarametyx.koii.dev/publication/targeting-a-bacterial-dnabii-protein-with-a-chimeric-peptide-immunogen-or-humanized-monoclonal-antibody-to-prevent-or-treat-recalcitrant-biofilm-mediated-infections-ebiomedicine-2020/2026-04-29T16:48:59-04:00https://clarametyx.koii.dev/publication/immunization-with-a-biofilm-disrupting-nontypeable-haemophilus-influenzae-vaccine-antigen-did-not-alter-the-gut-microbiome-in-chinchillas-unlike-oral-delivery-of-a-broad-spectrum-antibiotic-commonly/2026-04-29T16:49:22-04:00https://clarametyx.koii.dev/publication/redirecting-the-immune-response-towards-immunoprotective-domains-of-a-dnabii-protein-resolves-experimental-otitis-media-npj-vaccines-nature-2019/2026-04-29T16:49:39-04:00https://clarametyx.koii.dev/publication/monoclonal-antibodies-against-dna-binding-tips-of-dnabii-proteins-disrupt-biofilms-in-vitro-and-induce-bacterial-clearance-in-vivo-ebiomedicine-the-lancet-2016/2026-04-29T16:49:57-04:00https://clarametyx.koii.dev/publication/evaluation-of-the-kinetics-and-mechanism-of-action-of-anti-integration-host-factor-mediated-disruption-of-bacterial-biofilms-molecular-microbiology-2014/2026-04-29T16:50:15-04:00https://clarametyx.koii.dev/publication/biofilms-can-be-dispersed-by-focusing-the-immune-system-on-a-common-family-of-bacterial-nucleoid-associated-proteins-mucosal-immunology-2011/2026-04-29T16:52:39-04:00